Nutrien (NYSE:NTR) Stock Price Expected to Rise, Scotiabank Analyst Says

Nutrien (NYSE:NTR) had its price objective hoisted by stock analysts at Scotiabank from $60.00 to $62.00 in a report issued on Monday, Marketbeat Ratings reports. The firm presently has a “sector outperform” rating on the stock. Scotiabank’s price target indicates a potential upside of 15.68% from the company’s current price.

NTR has been the subject of a number of other reports. TD Securities lowered their target price on Nutrien from $63.00 to $61.00 and set a “buy” rating for the company in a report on Tuesday, November 12th. Wells Fargo & Company raised their price objective on shares of Nutrien from $53.00 to $56.00 and gave the stock an “equal weight” rating in a research report on Friday, February 21st. CIBC reiterated an “outperformer” rating and set a $55.00 target price (down previously from $60.00) on shares of Nutrien in a research report on Tuesday, December 10th. Mizuho raised their price target on shares of Nutrien from $52.00 to $55.00 and gave the stock a “neutral” rating in a report on Thursday, February 20th. Finally, UBS Group lifted their price target on shares of Nutrien from $53.00 to $54.00 and gave the company a “neutral” rating in a research note on Thursday, February 20th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, Nutrien presently has a consensus rating of “Moderate Buy” and an average price target of $60.11.

Nutrien Stock Up 2.7 %

Shares of NYSE NTR opened at $53.60 on Monday. The company’s 50 day moving average price is $49.66 and its 200-day moving average price is $48.35. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. Nutrien has a 52-week low of $43.69 and a 52-week high of $60.87. The company has a market capitalization of $26.25 billion, a P/E ratio of 39.12, a price-to-earnings-growth ratio of 1.19 and a beta of 0.81.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.09). The firm had revenue of $5.08 billion for the quarter, compared to the consensus estimate of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. Equities analysts forecast that Nutrien will post 3.72 earnings per share for the current year.

Hedge Funds Weigh In On Nutrien

Large investors have recently bought and sold shares of the stock. Fairway Wealth LLC purchased a new stake in shares of Nutrien in the fourth quarter valued at about $27,000. HHM Wealth Advisors LLC grew its position in Nutrien by 331.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock worth $28,000 after purchasing an additional 480 shares in the last quarter. Assetmark Inc. grew its position in Nutrien by 1,437.5% in the 4th quarter. Assetmark Inc. now owns 738 shares of the company’s stock worth $33,000 after purchasing an additional 690 shares in the last quarter. Asset Planning Inc purchased a new stake in Nutrien in the 4th quarter valued at about $35,000. Finally, Exchange Traded Concepts LLC boosted its stake in shares of Nutrien by 96.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock worth $38,000 after buying an additional 416 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.